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Background: A neuroimmune crosstalk between dendritic cells (DCs) and airway nerves in the lung has recently
been reported. However, the presence of DCs in airway sensory ganglia under normal and allergic conditions has
not been explored so far. Therefore, this study aims to investigate the localisation, distribution and proliferation of
DCs in airway sensory ganglia under allergic airway inflammation.
Methods: Using the house dust mite (HDM) model for allergic airway inflammation BALB/c mice were exposed to
HDM extract intranasally (25 μg/50 μl) for 5 consecutive days a week over 7 weeks. With the help of the
immunohistochemistry, vagal jugular-nodose ganglia complex (JNC) sections were analysed regarding their
expression of DC-markers (MHC II, CD11c, CD103), the neuronal marker PGP 9.5 and the neuropeptide calcitonin
gene-related peptide (CGRP) and glutamine synthetase (GS) as a marker for satellite glia cells (SGCs). To address the
original source of DCs in sensory ganglia, a proliferation experiment was also carried in this study.
Results: Immune cells with characteristic DC-phenotype were found to be closely located to SGCs and vagal sensory
neurons under physiological conditions. The percentage of DCs in relation to neurons was significantly increased by
allergic airway inflammation in comparison to the controls (HDM 51.38 ± 2.38% vs. control 28.16 ± 2.86%, p < 0.001).
The present study also demonstrated that DCs were shown to proliferate in jugular-nodose ganglia, however, the
proliferation rate of DCs is not significantly changed in the two treated animal groups (proliferating DCs/ total DCs:
HDM 0.89 ± 0.38%, vs. control 1.19 ± 0.54%, p = 0.68). Also, increased number of CGRP-positive neurons was found in
JNC after allergic sensitisation and challenge (HDM 31.16 ± 5.41% vs. control 7.16 ± 1.53%, p < 0.001).
Conclusion: The present findings suggest that DCs may migrate from outside into the ganglia to interact with sensory
neurons enhancing or protecting the allergic airway inflammation. The increase of DCs as well as CGRP-positive neurons
in airway ganglia by allergic airway inflammation indicate that intraganglionic DCs and neurons expressing CGRP may
contribute to the pathogenesis of bronchial asthma. To understand this neuroimmune interaction in allergic airway
inflammation further functional experiments should be carried out in future studies.
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Allergic bronchial asthma is a chronic inflammatory re-
spiratory disease characterised by airway obstruction,
bronchial hyperreactivity and airway inflammation with
the recruitment of a variety of immune cells including
dendritic cells (DCs) [1-3]. DCs are phagocytic cells that
are localised in many organs like in the skin, in the mu-
cosa of the intestines, the upper airways, the lungs and
the brain [2-5].
In the allergic sensitisation phase, DCs play a key role
as professional antigen presenting cells in the allergic
airway inflammation [3,4,6]. They capture the antigen,
process and subsequently present it on the MHC class II
molecules (MHC II) to naïve T lymphocytes in local
lymph nodes leading to cascades of the Th2-immune al-
lergic inflammatory processes [4,7,8]. Recently, the mat-
uration and differentiation of DCs have been described
to be modulated by many cytokines of immune cells as
well as neuropeptides such as calcitonin gene-related
peptide (CGRP) [9-11].
CGRP consists of 37 amino acids [12] and is bio-
synthesised and released from sensory neurons innervat-
ing the airways in response to different stimuli including
allergic airway inflammation [12-14]. CGRP released
from airway nerve fibres has the capacity to act as
chemoattractant factor for different immune cells such as
CD4+ T-lymphocytes, CD8+ T-lymphocytes, eosinophils
and DCs and to induce the proliferation of airway epithe-
lial cells [9,15-19]. On the other hand, DCs have the
capacity to release neurotrophins, which can activate
neurons leading to the production of neuropeptides caus-
ing neurogenic airway inflammation [20,21]. Previously,
DCs were found to be frequently associated anatomically
with CGRP-containing sensory nerve fibres of the air-
ways and skin [22,23].
Peripheral airway sensory nerve fibres are known to be
derived from the neuronal cell bodies which are located
in jugular-nodose ganglia complex (JNC) and able to
produce, store and release neuropeptides such as tachy-
kinins and CGRP to cause neurogenic inflammation
[24-26]. However, DCs in airway sensory ganglia have
not been explored under normal and allergic airway con-
ditions so far.
The present study, therefore, aimed to investigate the
localisation, distribution and proliferation of DCs and
CGRP immunoreactive (IR)-neurons in vagal sensory
jugular-nodose ganglia under allergic airway inflamma-




Female wild-type BALB/c-mice (6–8 weeks old) were
purchased from Charles River. The animals were held inregular 12 h dark/light cycles at a temperature of 22°C
and received laboratory food and tap water ad libitum.
The animals were acclimatised for at least 2 weeks prior
to the study. All animal experiments were performed in
strict concordance with the German animal protection
law and approved by the appropriate governmental au-
thority (No. 10/0207 and 14/2013).
HDM-mouse model
To induce chronic allergic airway inflammation, BALB/c
mice (n = 10) were exposed consecutively 5 days a week
within a total period of 7 weeks by intranasal instillation of
HDM extract (Greer Inc., Cat. No XPB82D3A2.5) with a
dose of 25 μg protein in 50 μl saline. A second group of an-
imals (n = 10) served as control and was treated intranasal
with 50 μl saline. Analyses were performed 24 h after the
last allergen challenge (Figure 1) [27,28].
In vivo proliferation study with EdU
(5-ethynyl-2’-deoxyuridine)
EdU is a nucleoside analog of thymidine and is incorpo-
rated into DNA during active DNA synthesis. Controls
and HDM-treated animals received an i.p. injection of
1 mg EdU (Invitrogen) in a volume of 200 μl 24 h before
sacrifice.
Bronchoalveolar lavage fluid (BALF)
Bronchoalveolar lavage was performed by instillation of
0.8 ml ice-cold PBS twice as described before [10]. The
BALF was centrifuged (320 × g, 10 min, 4°C) and the su-
pernatants were removed. The cell pellets were resus-
pended in 0.5 ml PBS and counted automatically with a
Casy® cell counter. Cytospots were prepared, stained ac-
cording to Pappenheim and differential cell counts were
evaluated.
Lung histology
For the assessment of the airway inflammation, acetone
fixed lung cryosections of allergen sensitised/challenged
and control animals were stained with hematoxylin and
eosin. Cryosections (10 μm) were prepared using a cryo-
stat (CM1950; Leica Cryostat, Nussloch, Germany) and
stained with hematoxylin and eosin (H&E) and Periodic
Acid Schiff (PAS) according to standard protocols.
Ganglion preparation
JNC ganglia were fixed in Zamboni solution (Morphisto –
Evolutionsforschung und Anwendung GmbH, Frankfurt
am Main, Germany) for six hours, rinsed overnight in
0.1 M phosphate buffered saline (PBS) and cryopro-
tected 24 h with 30% sucrose in 0.1 M PBS. All steps
above were performed at 4°C. The ganglia were embed-
ded in OCT and frozen in liquid nitrogen. Serial 8 μm
sections of the ganglia were prepared using a cryostat
Figure 1 Allergic sensitisation and challenge protocol of chronic HDM mouse model. The animals were systemically sensitised by intranasal
application of house dust mite 5 days a week for 7 weeks. All analyses were carried out 24 hours after the final challenge.
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(3-aminopropyltriethoxysilane) coated glass slides, dried
at room temperature for 30 min and then stored in the
freezer at −80°C.
Immunofluorescence staining
Every fourth section from serial sections of the JNC was
dried at room temperature for 15 min and then rehy-
drated for 5 min in PBS. To reduce nonspecific antibody
binding, the sections were incubated for 15 min at room
temperature in 5% normal serum of the host species of
the secondary antibody diluted in PBS. The sections
were incubated with primary antibodies against PGP 9.5,
MHC II, GS, CD11c, CD103, CD11b, F4/80, Iba1, GFAP,
CGRP, or the appropriate isotype control antibodies
(listed in Table 1) for 1 h at room temperature and then
overnight at 4°C. After rinsing with 0.1 M PBS twice,
the sections were incubated with secondary fluorescein
conjugated antibodies (listed in Table 1) for 2 h at room
temperature, for counterstaining the section then were
incubated with 100 μl DAPI (0.5 μg/ml, Carl Roth,
Germany) for 15 min at room temperature. Finally the
sections were washed twice with 0.1 M PBS, once with
double distilled water, mounted with fluorescent mount-
ing medium Prolong Gold (Invitrogen) and covered with
cover slips.
Quantitative analysis of MHC II IR-cells, CGRP ir-
neurons and PGP 9.5 ir-neurons was visualised with epi-
fluorescence microscopes (Axioskop 2 plus, Carl Zeiss
and Olympus BX5), and cell counting was performed using
the software ImageJ (National Institutes of Health). The
evaluations of MHC II IR-cells and CGRP IR-neurons were
normalised by the total neuron number and expressed as
percentages.
Confocal images were acquired by LSM 510 META
(Carl Zeiss, Jena, Germany). The Images were processed
using Imaris 4.5.2 (Bitplane, Zurich, Switzerland).
EdU staining and quantification of EdU-labelled cells
in JNC
EdU staining was conducted using Click-iT™ Cell Reac-
tion Buffer Kit and Alexa Fluor 594 azide (Invitrogen)according to the manufacture’s protocol. The JNC sec-
tions were rehydrated for 5 min in PBS and the blocked
with 5% normal serum. The sections were incubated
with 200 μl prepared Click-iT reaction cocktail for
30 min and then incubated with primary and secondary
antibodies as described above. Primary antibodies in-
cluded rat anti-mouse MHC class II (Biolegend) and
rabbit anti-mouse PGP 9.5 (Abcam). Secondary detec-
tion was performed with donkey anti-rat Cy2 and don-
key anti-rabbit DyLight 647 (Jackson ImmunoResearch)
(Table 1). DAPI was used for counterstaining.
For the quantification, 16 sections of each mouse were
analysed. Only the EdU-labelled and MHC II- and DAPI-
positive cells were observed for quantification of proliferating
cells. Evaluations of proliferating, MHC II positive cells with
an EdU-labelled nucleus were normalised with the total
MHC II positive cells and expressed as percentages.
Statistical analysis
Data is given as mean ± SEM. Statistical significance be-
tween groups was analysed with unpaired t-test using
GraphPad Prism 4.03. Results of P values < 0.05 were
considered significant.
Results
HDM induces allergic airway inflammation
HDM induced chronic allergic airway inflammation is
indicated by the recruitment of eosinophils, neutrophils,
lymphocytes and macrophages to the lung (Figure 2A).
The histological analysis with H&E and PAS staining of
the lung tissues showed massive infiltration of mono-
nuclear cells (Figure 2B) and a high mucus secretion
(Figure 2C) in HDM-sensitised and -challenged mice. In
contrast, the lung sections of control mice did not con-
tain inflammatory cell aggregates (Figure 2D) and no
mucus secretion was detected (Figure 2E).
DCs are located in JNC and increased during allergic
airway inflammation
JNC sections were analysed by immunofluorescent staining
for the expression of pan-neuronal marker PGP 9.5 and
MHC II to identify sensory neurons and DCs and assess the
Table 1 List of antibodies used in this study
Antibody Source Dilution
Primary purified antibodies
Rabbit polyclonal antibody against mouse, human PGP 9.5 Abcam, Cambridge, UK 1:200
Rat monoclonal antibody against mouse I-A/I-E BioLegend, San Diego, USA 1:200
Goat polyclonal antibody against mouse CGRP Acris, Herford, Germany 1:400
Armenian hamster monoclonal antibody against mouse CD11c Abcam, Cambridge, UK 1:100
Armenian hamster monoclonal antibody against mouse CD103 eBioscience, San Diego, USA 1:100
Rat monoclonal antibody against mouse CD11b eBioscience, San Diego, USA 1:100
Rat monoclonal antibody against mouse F4/80 eBioscience, San Diego, USA 1:100
Rabbit polyclonal antibody against mouse glutamine synthetase (GS) Abcam, Cambridge, UK 1:500
Rabbit Rabbit polyclonal antibody against Iba1 Wako Chemicals, Japan 1:300
Goat polyclonal antibody against GFAP Abcam, Cambridge, UK 1:200
Isotype control purified antibodies
Rabbit IgG Dianova, Hamburg, Germany 1:5000
Rat IgG 2b kappa BioLegend, San Diego, USA 1:200
Goat IgG R&D systems, 1:300
Armenian Hamster IgG BioLegend, San Diego, USA 1:200
Secondary antibodies
DyLight 488 conjugated Donkey Anti-Rabbit IgG antibody Jackson ImmunoResearch, INC., Baltimore, USA 1:400
Cy3 conjugated Donkey Anti-Rat IgG antibody Jackson ImmunoResearch, INC., Baltimore, USA 1:500
Cy3 conjugated Donkey Anti-Rabbit IgG antibody Jackson ImmunoResearch, INC., Baltimore, USA 1:400
DyLight 488 conjugated Donkey Anti-Goat IgG antibody Jackson ImmunoResearch, INC., Baltimore, USA 1:400
Dylight 649 conjugated Goat Anti-Armenian Hamster IgG antibody Jackson ImmunoResearch, INC., Baltimore, USA 1:400
DyLight 649 conjugated Donkey Anti-Rabbit IgG antibody Jackson ImmunoResearch, INC., Baltimore, USA 1:400
Cy3 Conjugated Donkey Anti-Goat IgG Jackson ImmunoResearch, INC., Baltimore, USA 1:500
Cy5 conjugated Donkey Anti-Rat IgG antibody Jackson ImmunoResearch, INC., Baltimore, USA 1:400
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nerve fibres were strongly immunoreactive for PGP 9.5 indi-
cating that these cells were neurons and nerve fibres. Nerve
fibres formed bundles crossing the ganglia. Under physio-
logical and allergic conditions, DCs were observed to be
widely distributed over the whole JNC and were located be-
tween the neurons and nerve fibres which were immunore-
active for PGP 9.5 (Figure 3).
To determine how the number of DCs in JNC changed
during allergic airway inflammation, DCs and neurons
in JNC of HDM-treated and control mice were quanti-
fied by using MHC II- and the pan-neuronal marker
PGP 9.5- immunoreactivity. The percentage of DCs in rela-
tion to the overall neurons was significantly increased in
HDM-treated mice (Figure 3C) if compared to the controls
(Figure 3D) (DCs/neurons: HDM 51.38 ± 2.38% (n = 9) vs.
control 28.16 ± 2.86 (n = 10), p < 0.001, Figure 3E).
To confirm whether the increase of DCs in JNC is
caused by the targeted infiltration or global infiltration,
the presence of MHC II-IR cells in trigeminal ganglia,
which partly innervate the upper airways, has also beenexamined by immunohistochemistry. MHC II-IR cells
have been found in trigeminal ganglia under physiological
condition, and their numbers were not significantly chan-
ged by allergic airway inflammation (Figure 3F, G, H).
Phenotypic characterisation of DCs in JNC
To identify and characterise DCs phenotypically, various
surface markers of DCs have been used for this study. In
this respect, JNC sections were stained with antibodies
against different markers of DCs such as MHC II,
CD11c, CD11b, CD103, and Iba1. To discriminate DCs
from macrophages, that also express these markers, the
ganglia sections were additionally stained with the anti-
body against F4/80, which is the best known and exten-
sively referenced marker for mouse macrophages. The
staining results demonstrated a substantial number of
cells in JNC that were strongly immunoreactive for
MHC II, CD103 and Iba1. MHC II IR-cells have been
found to be totally colocalised with CD103 and Iba1.
The staining for CD11b and F4/80 marker did not
show any immunoreactivity in MHC II IR-cells. Most
Figure 2 The inflammatory response in the lungs observed after continuous expose to HDM. Bronchoalveolar lavage fluid (BALF) cells
differentiation (A). Eosinophils, neutrophils, lymphocytes and macrophages in BALF demonstrated inflammation in the lungs of HDM-exposed
mice, in comparison with control mice. Results are expressed as mean ± SEM. **P < 0.01, ***P < 0.001 (unpaired two-tailed t-test). Representative
photomicrographs of H&E (B,D,G) and PAS (C,E,F) stained lung sections. The lung sections from HDM-sensitised and challenged mice showed an
infiltration of mononuclear cells (B) and a highly mucus secretion (C) in the airways, whereas the lungs of the control mice do not contain
aggregated inflammatory cells (D) and mucus secretion (E). F and G: larger magnifications of C and E. Scale bars of B and D: 200 μm, scale
bars of C and E: 100 μm.
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CD11c (CD11c-IR cells/MHC II-IR cells: HDM group:
98.84 ± 0.70% (n = 4), control group: 97.36 ± 0.60% (n = 5)).
These findings demonstrated a subpopulation of DCs in
JNC with these markers MHC II+ CD11c+ CD103+ Iba1+
F4/80− CD11b− (Figure 4).
Discrimination between DCs and glia cells in JNC
The expression of MHC II molecules has been described
not only in conventional antigen-presenting cells (APC)
but also in human trigeminal satellite glia cells (SGCs)
[29]. Therefore, the discriminations of DCs from SGCs
and other glia cells in mouse airway ganglia were deter-
mined. JNC sections were stained with the SGC marker
glutamine synthetase (GS), astrocyte marker glial fibril-
lary acidic protein (GFAP) and the APC marker MHC II.
The results showed that the GS positive cells were locatedaround neurons and formed an envelope around the sen-
sory neurons. SGCs in JNC were found to be small-sized
cells with a thin cytoplasm and a small cell nucleus without
APC phenotype. These cells were negative for MHC II-
immunoreactivity indicating that they were not identical
with DCs, characterised with MHC II. Furthermore, GS
positive cells display a different anatomical structure than
the MHC II positive cells identified as DCs in JNC. Further
analysis demonstrated that MHC II-IR cells in JNC are
negative for GFAP and therefore they do not belong to
astrocyte subpopulation of glia cells (Figure 5).
Increase of CGRP-immunoreactive-neurons in JNC in
allergic airway inflammation
Similarly to the finding for DCs, the percentage of CGRP
ir-neurons in relation to the JNC-overall neurons was
also found to be significantly elevated in HDM-treated
Figure 3 Quantification of dendritic cells in JNC and trigeminal ganglia. Zamboni fixed sections of JNC were stained with MHC II for DCs
and PGP 9.5 for neurons. A: Overview of a JNC section stained for MHC II and PGP 9.5. B: An enlargement of DCs and neurons by using confocal
microscope LSM 510 META (Carl Zeiss, Jena, Germany) with a 40x objective. Immunofluorescence analysis revealed amount of DCs, which are located
next to the neuron in JNC of HDM treated mice (C) as well as control mice (D) and their number increased significantly during allergic airway
inflammation. E: The quantification of DCs in JNC of control and HDM-treated mice. The results were expressed as percentages of MHC II positive
cells in relation to PGP 9.5 positive neurons, H HDM 51.38 ± 2.38% (n = 9) vs. control 28.16 ± 2.86 (n = 10), p < 0.001. MHC II-IR cells have been found in
trigeminal ganglia of control (F) and HDM treated mice (G). H: The quantification of MHC II-IR cells in trigeminal ganglia of control and HDM groups.
The results were expressed as percentages of MHC II-IR cells in relation to PGP 9.5 positive neurons, HDM 52.69 ± 0.86% (n = 4) vs control 52.90 ± 1.36%
(n = 4). Images A, C, D, F, G were acquired with Olympus BX51 (Tokyo, Japan), Scale bar in A: 500 μm, in B: 20 μm, in C, D, F, G: 100 μm.
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(Figure 6B) (CGRP-positive neurons/total neurons: HDM
31.16 ± 5.41% (n = 9) vs. control 7.16 ± 1.53% (n = 10),
p < 0.001, Figure 6C). Additionally, MHC II-positive cells
have been found to have an overall distribution on the JNC
slices without any preferentially location to CGRP-positive
neurons (Figure 6D).
Proliferating DCs in JNC during allergic airway
inflammation
To examine whether DCs proliferated in JNC or mi-
grated from outside into the ganglia during allergic airwayinflammation, the animals were injected with EdU, which
is incorporated with DNA of dividing cells. Systemic
administration of EdU 24 h before analysis assured the
detection of proliferating cells. The proliferating DCs in
two groups were evaluated and expressed as percentage
of MHC II positive cells with EdU-labelled nucleus/
total MHC II positive cells. The results showed no signifi-
cant change of proliferating DCs ratio between two groups
(proliferating DCs/ total DCs: HDM 0.89 ± 0.38%, (n = 4)
vs. control 1.19 ± 0.54%, (n = 5), p = 0.68, Figure 7G). Add-
itionally, proliferation of neurons as well as SGCs was not
found in the experiments. Further EdU experiments for
Figure 4 (See legend on next page.)
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Figure 4 Phenotypic characterisation of DCs in JNC. JNC sections were stained for different cell markers and images were acquired with
confocal microscope LSM 510 META (Carl Zeiss, Jena, Germany) using a 40x objective and Olympus BX51 (Tokyo, Japan) using a 20x, 40x
objectives. The Immunofluorescence analysis showed the immune cells in JNC positive for MHC II and CD11c (A), positive for MHC II and CD103
(B), positive for CD11c and negative for CD11b (C), positive for MHC II and Iba1 (D), positive for Iba1 and negative for F4/80 (E). F: Positive
control of CD11b antibody in the lung tissue. G: Positive control of CD11c antibody in trigeminal ganglion. Yellow cells in A, B, C are neurons,
which are stained with antibody against PGP 9.5. H: The quantification of CD11c-IR cells in JNC, the results were expressed as percentages of
CD11c-IR cells in relation to MHC II–IR cells. Scale bars represent in A, B, C: 20 μm, in D, E: 50 μm.
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sue of HDM treated mice. The finding showed a large
population of MHC II-IR cells of the lung also strongly
positive for EdU, showing the DCs proliferation in the
lung (Figure 7H).
Discussion
Dendritic cells play a pivotal role as antigen sampling
and presenting cells in the initiation and development of
allergic response such as allergic airway inflammation
[3,4,8]. Previous studies have revealed that DCs were
found to be localised in the neighbourhood of peripheral
CGRP-positive nerve fibres in the airways [22]. The role
of this DC-nerve interaction in allergic airway inflamma-
tion, however, has not been clear yet.
CGRP has been discussed to have the capacity to modu-
late DCs during the allergic airway inflammation. CGRP is
known to be produced by the cell bodies located in JNC,
anterogradely transported and released by the peripheral
nerve fibres innervating the airways [12-14]. In this respect,
the present study aimed to investigate the localisation, dis-
tribution and proliferation of DCs in JNC by using HDM
mouse model for allergic airway inflammation.Figure 5 Distinction between DCs and glia cells in JNC. A: DCs are imm
immunoreactive for glutamine synthetase (GS). C: MHC II-IR cells have no o
SGCs and DCs are stained with DAPI. The dendritic cells with immunoreact
dendritic cells expressed no GFAP (E). F: merged representation of MHC II
Scale bars: 50 μm.eosinophilic
After continuous intranasal administration with HDM
extract, a chronic airway inflammation was induced as
previously reported [27]. In accordance to other studies,
inhalation of HDM extract led to a significant increase
number of neutrophils, macrophages and lymphocytes
[27,28]. With the characteristic of mixed and
neutrophilic inflammation, the HDM mouse model be-
comes an interesting animal model that may closely reflect
the situation of severe bronchial asthma in human [1].
Interestingly, for the first time, cells expressing MHC II
molecules were identified in JNC of mice under physio-
logical conditions. The immunofluorescence analysis re-
vealed that these cells belong to the immune cell
population rather than to the nervous system as they
were non-reactive for the pan-neuronal marker PGP 9.5.
Additionally, these immune cells exhibited DC phenotypes
as they displayed high immunoreactivity for MHC II and
CD103 while negative for CD11b- and F4/80-immunore-
activity. Most (about 98%) of MHC II-IR cells were immu-
noreactive for CD11c indicating these cells are DCs. MHC
II-IR cells have also been found to be totally colocalised
with Iba1, which has been reported to be expressed in
of the recruitment of eosinophils as well as a substantialunoreactive with MHC II. B: Satellite glia cells (SGCs, arrows) are
verlaps with SGCs immunoreactive for GS, the separate cell nucleus of
ivity for MHC II (D) were also stained with astrocyte marker GFAP, these
and GFAP. G: positive control of GFAP antibody in mouse brain section.
Figure 6 Increased numbers of CGRP-positive neurons under allergic condition. The JNC sections of HDM treated animals and control
animals were stained with antibodies against neuropeptides CGRP and PGP 9.5. The amount of CGRP positive neurons increased significantly
during allergic airway inflammation (A) in comparison to that of the controls (B). Scale bars: 50 μm. Images were acquired with Axioskop 2 plus
(Zeiss) using a 40x objective. C: The quantification of CGRP ir-neurons in JNC of control and HDM-treated mice. The results were expressed
as percentage of CGRP-IR-neurons in relation to all PGP 9.5 positive neurons, HDM 31.16 ± 5.41% (n = 9) vs. control 7.16 ± 1.53% (n = 10), p < 0.001.
D: MHC II-positive cells distribute overall on the JNC slices without any preferentially location to CGRP-positive neurons. Image was acquired with
confocal microscope LSM 510 META (Carl Zeiss, Jena, Germany), scale bar: 50 μm.
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skin [5,30,31]. A very small population with MHC II-IR
did not express CD11c (<2%). These cell types are still
unknown and remain to be investigated in future study.
The localisation of DCs within the sensory ganglia was
found to be widely distributed on the whole ganglia and
between SGCs and/or neurons. Recently, other neuronal
cells, such as SGCs in human trigeminal ganglion, have
also been shown to express MHC II [29]. However, the
present findings revealed that SGCs in mouse JNC to
be negative for MHC II. The contrary findings of the
SGC population may be caused by the ganglionic- and
species-specific differences between mouse and human
[29,32]. The exact role of SGCs in JNC under physio-
logical and allergic situations remains to be investi-
gated in future experiments.
For the discrimination of DC migration into the ganglia
as a targeted infiltration and systemic infiltration, further
studies have been carried out in trigeminal ganglia. Incontrast to the JNC, where the numbers of DCs were
significantly increased during allergic airway inflamma-
tion, the numbers of MHC II-IR cells in trigeminal gan-
glia, however, were not changed. These contrary findings
may be caused by the ganglionic- or organ-specific differ-
ences between JNC and trigeminal ganglia. Anatomically,
trigeminal ganglia are located inside the cranium, whereas
JNC are found to be under the skullbase. Additionally, the
two ganglia have different embryonic development.
The findings of the increase of DCs in the JNC lead to
further questions of their origin. The results of the pro-
liferation study suggest that DCs may move from the
systemic blood circulation into JNC by passing through
the ganglion-blood barrier. In contrast to the brain–
blood barrier, the ganglion-blood barrier is known to be
only discontinuously formed [33]. Alternatively, DCs may
reach the JNC along the vagus from the peripheral airways
by retrograde migration when their numbers in the airways
and the blood system were to be enhanced during allergic
Figure 7 Quantitative analysis of proliferating DCs in JNC. A: MHC II staining of DCs. B: EdU detection of proliferating DCs (arrows). C: Nucleus
staining with DAPI. D: Neurons positive for PGP 9.5. E: Merged representation of the images shown in A-D. F: An enlargement of EdU positive cell.
G: Quantification of proliferating DCs in JNC of HDM treated and control mice. Ganglion sections were stained for EdU, MHC II, PGP 9.5 and
nucleus. The proliferating DCs, which are positive with MHC II and EdU labelled nucleus, and total number of DCs were evaluated. The results were
expressed as percentages of proliferating DCs/total DCs. The proliferation rate of DCs in HDM treated mice 0.89 ± 0.38% (n = 4) and control mice
1.19 ± 0.54% (n = 5), p = 0.68. H: The positive control of EdU in the lung. The figures showed amount of proliferating MHC II-IR cells and other cell
types in the lung. Scale bars: 100 μm in A, B, C, D, 50 μm in H.
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also may play a substantial role in the immune response to
protect the neurons against viral and bacterial infection,
virus replication and bacterial spread without any neuronal
destruction [36-39]. In this respect, other immune cells like
T cells and macrophages were recently found inside the
HSV-1 latently infected trigeminal ganglia [36]. However,
the origin and function of the DCs in JNC under normal
and allergic airway conditions remains to be answered in
future studies.
With respect to the neuroimmune interaction, matur-
ation, migration and function of DCs during allergic air-
way inflammation have been reported to be modulated
by neuropeptides like the calcitonin gene-related peptide
(CGRP), tachykinins and vasoactive intestinal peptide
(VIP) released from airway nerves fibers [9,10,13,14]. In
view of modulatory effects of CGRP on DCs, sensory
neurons in JNC were investigated for CGRP-expression.
The significant increase of CGRP-IR-neurons and the el-
evated numbers of DCs in allergic airway response sug-
gest that there may be a functional relationship between
DCs and CGRP-IR-neurons.
The increased of CGRP-IR-neurons in HDM-treated
mice may have an influence on the migration, prolifera-
tion or function of DCs in JNC. With respect to the effect
of CGRP in allergic airway inflammation, a proinflamma-
tory or antiinflammatory role of CGRP in allergic airway
inflammation is therefore still controversially discussed
[9,10,12,40]. The intragangionic release of CGRP within
JNC has not been demonstrated so far in vivo. Previous
study on rat has reported about the release of CGRP from
isolated JNC after stimulation with different substances
such as capsaicin, nitric oxide donor sodium nitroprusside
[41]. Our findings showed an increase of CGRP-positive
neurons in JNC, but a release of CGRP from the neuron
into the ganglia could not be demonstrated in the present
study. Based on this observation, we suggest that CGRP
may be paracrinely released from the neurons or antero-
gradely transported to the peripheral nerve endings and
liberated into the airways. The exact role of CGRP in sen-
sory neurons concerning the modulation of DC-function
during allergic airway response remains to be elucidated
in future studies.
Conclusion
The present study revealed for the first time the existence
of immune cells with DC phenotype within JNC. The in-
crease of DCs and CGRP-positive neurons in airway gan-
glia caused by allergic airway inflammation indicates that
ganglia DCs and neurons expressing CGRP may contrib-
ute to the pathogenesis of bronchial asthma. These find-
ings demonstrate that DCs may migrate from outside
into the ganglia to interact with sensory neurons enhan-
cing or protecting the allergic airway inflammation.Further studies should be carried out to explore the inter-
action of DCs and neurons in airway sensory ganglia dur-
ing allergic airway inflammation.
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